Page last updated: 2024-10-15

quillaja saponins

Description

Quillaja Saponins: Natural detergents made up of a heterogeneous mixture of molecules having a triterpenoid core structure. They vary in aglycone (sapogenin) and sugar moieties, including glucose. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID138756749
MeSH IDM0399297

Synonyms (7)

Synonym
quillaja saponins
69v6789zru ,
beta-d-glucopyranosiduronic acid, (3beta,4alpha,16alpha)-17-carboxy-16-hydroxy-23-oxo-28-norolean-12-en-3-yl
einecs 215-731-2
quillaja saponin
unii-69v6789zru
hsdb 2171

Toxicity

ExcerptReference
" Most of the adjuvants are toxic at certain doses, and toxicity varies in different species."( Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus).
Jung, SJ; Kim, HY; Park, CS; Vinay, TN, 2014
)

Compound-Compound Interactions

ExcerptReference
" gondii (rSAG3) were immunized into BALB/c mice alone or in combination with Quil A (rSAG3/Quil A), and then evaluated the protective immunity in vivo and in vitro against murine toxoplasmosis."( Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.
Ahn, MH; Lee, JH; Lee, YH; Nam, HW; Shin, DW, 2007
)
" Mice immunized with rSAG3 alone or in combination with Quil A produced significantly more specific IgG2a antibody, whereas specific IgG1 antibody titers did not increase."( Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.
Ahn, MH; Lee, JH; Lee, YH; Nam, HW; Shin, DW, 2007
)

Dosage Studied

ExcerptReference
"Sustained-release vaccines offer the potential to reduce, or obviate, the need for repeated dosing of vaccines."( Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation.
Eberhardt, F; Hook, S; Myschik, J; Rades, T, 2008
)
" A dose-response and adjuvant trial showed best results were achieved with 250 μg of antigen and 5mg of the adjuvant QuilA, which was 5 times the recommended sheep dose."( Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis).
Anderson, GA; Gulnur, T; Heath, DD; Huang, Y; Lightowlers, MW; Robinson, C; Shakes, T; Shi, B; Zhang, Z, 2012
)
" Moreover, there are no standard dosage limits set for adjuvant use in fish vaccines."( Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus).
Jung, SJ; Kim, HY; Park, CS; Vinay, TN, 2014
)
"The development of vaccine delivery systems that will remove or reduce the need for repeated dosing has led to the investigation of sustained release systems."( Impact of implant composition of twin-screw extruded lipid implants on the release behavior.
Bobbala, S; Engert, J; Even, MP; Hook, S; Kooi, KL; Winter, G, 2015
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (232)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (7.33)18.7374
1990's43 (18.53)18.2507
2000's60 (25.86)29.6817
2010's96 (41.38)24.3611
2020's16 (6.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials11 (4.58%)5.53%
Reviews10 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other219 (91.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]